Learn More
Description
This gene encodes a voltage-gated sodium channel which plays a significant role in nociception signaling. Mutations in this gene have been associated with primary erythermalgia, channelopathy-associated insensitivity to pain, and paroxysmal extreme pain disorder. [provided by RefSeq
Specifications
Specifications
| Antigen | SCN9A |
| Applications | Immunocytochemistry, Immunofluorescence, Immunohistochemistry, Immunoprecipitation, Western Blot |
| Classification | Monoclonal |
| Clone | S68-6 |
| Conjugate | Unconjugated |
| Description | Mouse monoclonal antibody raised against partial recombinant SCN9A. |
| Dilution | Western Blot (1-10 ug/mL) Immunohistochemistry (0.1-1.0 ug/mL) Immunocytochemistry (0.1-1.0 ug/mL) Immunofluorescence (1.0-10 ug/mL) The optimal working dilution should be determined by the end user. |
| Formulation | In PBS, pH 7.4 (50% glycerol, 0.09% sodium azide) |
| Gene | SCN9A |
| Gene Alias | ETHA/NE-NA/NENA/Nav1.7/PN1 |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.